Katsumata N, Shiraishi H, Suzuki H
Department of Anesthesiology, Surugadai Nihon University Hospital, Tokyo.
Masui. 1991 May;40(5):801-6.
The neuromuscular blocking effects of vecuronium 10 mg preparation under enflurane anesthesia have been investigated in 22 patients having elective surgeries. The effect on cardiovascular system in man and laboratory examinations were also investigated. The results are as follows; 1. Onset time (time from end of injection until maximal blockade) after the dose of 0.08 or 0.1 mg.kg-1 of vecuronium bromide was about 2.6 minutes and 1.9 minutes, respectively. 2. Clinical duration of action (time from end of injection until 25% recovery of twitch) in the 0.1 mg.kg-1 group (about 50.1 minutes) was significantly longer than that in the 0.08 mg.kg-1 group (about 35.6 minutes). 3. Recovery time (time elapsing between 25 and 75% recovery of twitch) with neostigmine was 5.3 minutes (0.08 mg.kg-1) and 4.2 minutes (0.1 mg.kg-1). 4. Blood pressure was stable before and after the injection of vecuronium and no abnormal change related to the test drug was observed in the laboratory examinations. These data show that the efficacy and safety of the vecuronium 10 mg preparation are the same as those of the 4 mg preparation reported previously. In conclusion, it is considered that vecuronium 10 mg preparation is clinically useful because it is unnecessary to dissolve the drug frequently with injectable water.
对22例行择期手术的患者,研究了安氟醚麻醉下10mg维库溴铵制剂的神经肌肉阻滞作用。还研究了其对人体心血管系统的影响及实验室检查结果。结果如下:1. 溴化维库溴铵剂量为0.08或0.1mg·kg-1时,起效时间(从注射结束至最大阻滞的时间)分别约为2.6分钟和1.9分钟。2. 0.1mg·kg-1组的临床作用持续时间(从注射结束至颤搐恢复25%的时间)约为50.1分钟,显著长于0.08mg·kg-1组(约35.6分钟)。3. 新斯的明作用下的恢复时间(颤搐从恢复25%至75%的时间),0.08mg·kg-1组为5.3分钟,0.1mg·kg-1组为4.2分钟。4. 注射维库溴铵前后血压稳定,实验室检查未观察到与受试药物相关的异常变化。这些数据表明,10mg维库溴铵制剂的有效性和安全性与先前报道的4mg制剂相同。总之,认为10mg维库溴铵制剂临床有用,因为无需频繁用注射用水溶解药物。